G. Socie et al., AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL FINDINGS, INCIDENCE AND RISK-FACTORS, British Journal of Haematology, 86(3), 1994, pp. 624-628
In the present study we describe the incidence, clinical course, and m
anagement of avascular necrosis of bone following allogeneic bone marr
ow transplantation, and identify risk factors related to its developme
nt. All patients developing avascular necrosis of bone after allogenei
c bone marrow transplantation between January 1974 and September 1992
were included in the analysis and were studied using the Hopital Saint
Louis Bone Marrow Transplant Database and hospital records. 27/727 al
logeneic transplant recipients developed avascular necrosis leading to
an 8.1% incidence at 5 years, by product limit estimate, ranging from
5% to 11.2%. Symptoms developed 119-1747 d (median 398 d) after trans
plantation. In these 27 patients a total of 52 joints were affected (m
ean 1.92 per patient, range 1-7). The hip joint was most often affecte
d (69% of patients). All patients had joint pain that led to diagnosis
by means of standard radiographs with or without the help of techneti
um-99 scans and/or magnetic resonance imaging. All but three patients
received steroid therapy for acute graft-versus-host disease. Among 10
factors tested, three were shown to be significantly linked to an inc
reased risk for developing avascular necrosis by multivariate analysis
: male gender (relative risk (RR) 4.72, P = 0.002), age older than 16
(RR = 3.87, P = 0.004), and acute graft-versus-host disease requiring
steroid therapy (RR = 6.30, P = 0.0002). 10 patients (37%) required jo
int replacement within 19 months (range 2-42) following diagnosis of a
vascular necrosis. In conclusion, avascular necrosis of bone is a freq
uent late complication of allogeneic bone marrow transplantion causing
significant morbidity and requiring replacement surgery in one-third
of affected patients. In this 18-year single-centre survey, older age,
male gender and steroid therapy given for acute graft-versus-host dis
ease were shown to independently increase the risk of avascular necros
is of bone.